Last checked at 10 Apr 2012 12:01
For immediate release | 10 April 2012 |
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Notice of AGM
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is pleased to announce that its Notice of the Annual General Meeting, which will be held on 23 May 2012, is now available on the Company's website at www.alliancepharma.co.uk.
Printed copies of the Annual Report and Accounts and the Notice have been posted to shareholders today and may also be requested by email at ir@alliancepharma.co.uk.
For further information:
Alliance Pharma plc | + 44 (0) 1249 466966 |
John Dawson, Chief Executive | |
Richard Wright, Finance Director | |
Buchanan | + 44 (0) 20 7466 5000 |
Mark Court / Jessica Fontaine | |
Numis Securities Limited | + 44 (0) 20 7260 1000 |
Nominated Adviser: Michael Meade / Oliver Cardigan | |
Corporate Broking: David Poutney |
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 50 pharmaceutical products and continues to explore opportunities to expand the range.
Alliance's products are prescribed in the treatment of a wide range of conditions and include products used in the treatment of dermatological conditions, in oncology, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies with their prescription requirements.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.